248 related articles for article (PubMed ID: 3927929)
21. Prostaglandin-stimulated gastric mucus secretion in man.
Domschke W; Domschke S; Hornig D; Demling L
Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):292-4. PubMed ID: 358722
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man.
Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
Hepatogastroenterology; 1990 Feb; 37(1):124-7. PubMed ID: 2107135
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat.
Hirst BH; Reed JD; Shaw B; Coy DH; Schally AV
Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):208-12. PubMed ID: 352081
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
Simon B; Dammann HG; Müller P
Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
[TBL] [Abstract][Full Text] [Related]
25. Ranitidine inhibits gastric acid and pepsin secretion following sham feeding.
Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
Hepatogastroenterology; 1980 Oct; 27(5):377-80. PubMed ID: 6110626
[TBL] [Abstract][Full Text] [Related]
26. The effects of chronic consumption of heroin on basal and vagal electrical-stimulated gastric acid and pepsin secretion in rat.
Rafsanjani FN; Maghouli F; Vahedian J; Esmaeili F
Saudi Med J; 2004 Oct; 25(10):1356-9. PubMed ID: 15494801
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: a synthetic prostaglandin E1 methyl ester analog.
Akdamar K; Agrawal N; Ertan A
Am J Gastroenterol; 1982 Dec; 77(12):902-4. PubMed ID: 6816064
[TBL] [Abstract][Full Text] [Related]
28. Effect of doxepin on gastric secretion in man.
Giercksky KE; Oyen D; Andersen OK; Burhol P
Scand J Gastroenterol; 1984 Jul; 19(5):661-4. PubMed ID: 6433435
[TBL] [Abstract][Full Text] [Related]
29. The effects of impromidine and pentagastrin on gastric output of histamine, acid and pepsin in man.
Peden NR; Boyd EJ; Callachan H; Shepherd DM; Wormsley KG
Hepatogastroenterology; 1982 Feb; 29(1):30-4. PubMed ID: 6212525
[TBL] [Abstract][Full Text] [Related]
30. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
Dammann HG; Rehner M; Walter TA; Müller P; Simon B
Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
[TBL] [Abstract][Full Text] [Related]
31. Influence of chronic rioprostil treatment on gastric endocrine function.
Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
[TBL] [Abstract][Full Text] [Related]
32. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
Hammond JB; Offen WW
Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
[TBL] [Abstract][Full Text] [Related]
33. Gastric secretory response to different doses of carbachol and pentagastrin in man.
Vatn MH; Myren J
Scand J Gastroenterol; 1976; 11(4):421-5. PubMed ID: 779004
[TBL] [Abstract][Full Text] [Related]
34. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
[TBL] [Abstract][Full Text] [Related]
35. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
Vantrappen G; Janssens J
Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
[TBL] [Abstract][Full Text] [Related]
36. A comparison of pirenzepine and cimetidine inhibition of centrally-mediated gastric acid and pepsin secretion in the gastric-fistula cat.
Browning JG; Heathcote BV
Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):288-96. PubMed ID: 6411019
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects.
Miwa M; Tani N; Miwa T
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):214-7. PubMed ID: 6325352
[TBL] [Abstract][Full Text] [Related]
38. Effect of rioprostil, an oral prostaglandin E1 analogue, on lower oesophageal sphincter pressure and on the motility of the distal oesophagus in healthy volunteers.
Baunack AR; Demol P; Froese G; Kuhlmann J; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():120-5; discussion 125-6. PubMed ID: 2510255
[TBL] [Abstract][Full Text] [Related]
39. Effects of an orally administered prostaglandin analogue (16, 16-dimethyl prostaglandin E2) on human gastric secretion.
Wilson DE; Winnan G; Quertermus J; Tao P
Gastroenterology; 1975 Sep; 69(3):607-11. PubMed ID: 1158077
[TBL] [Abstract][Full Text] [Related]
40. Effect of secretin on pentagastrin-stimulated gastric acid and pepsin secretion after vagotomy in man.
Berstad A; Petersen H; Roland M; Liavåg I
Scand J Gastroenterol; 1973; 8(2):119-22. PubMed ID: 4572447
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
